These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
176 related items for PubMed ID: 15148271
1. Double-blind, randomized controlled trial on the effect of leukocyte-depleted erythrocyte transfusions in cardiac valve surgery. Bilgin YM, van de Watering LM, Eijsman L, Versteegh MI, Brand R, van Oers MH, Brand A. Circulation; 2004 Jun 08; 109(22):2755-60. PubMed ID: 15148271 [Abstract] [Full Text] [Related]
2. Cost-effectiveness of leucocyte-depleted erythrocyte transfusion in cardiac valve surgery. van Hulst M, Bilgin YM, van de Watering LM, de Vries R, van Oers MH, Brand A, Postma MJ. Transfus Med; 2005 Jun 08; 15(3):209-17. PubMed ID: 15943705 [Abstract] [Full Text] [Related]
3. Universal leukocyte reduction of transfused red cells does not provide benefit to patients undergoing cardiac surgery. Capraro L, Kuitunen A, Vento AE, Suojaranta-Ylinen R, Kolho E, Pettilä V. J Cardiothorac Vasc Anesth; 2007 Apr 08; 21(2):232-6. PubMed ID: 17418737 [Abstract] [Full Text] [Related]
4. Comparison of two red-cell transfusion strategies after pediatric cardiac surgery: a subgroup analysis. Willems A, Harrington K, Lacroix J, Biarent D, Joffe AR, Wensley D, Ducruet T, Hébert PC, Tucci M, TRIPICU investigators, Canadian Critical Care Trials Group, Pediatric Acute Lung Injury and Sepsis Investigators (PALISI) Network. Crit Care Med; 2010 Feb 08; 38(2):649-56. PubMed ID: 19789443 [Abstract] [Full Text] [Related]
5. Is increased mortality associated with post-operative infections after leukocytes containing red blood cell transfusions in cardiac surgery? An extended analysis. Bilgin YM, van de Watering LM, Eijsman L, Versteegh MI, van Oers MH, Brand A. Transfus Med; 2007 Aug 08; 17(4):304-11. PubMed ID: 17680957 [Abstract] [Full Text] [Related]
6. Efficacy of recombinant human erythropoietin in critically ill patients admitted to a long-term acute care facility: a randomized, double-blind, placebo-controlled trial. Silver M, Corwin MJ, Bazan A, Gettinger A, Enny C, Corwin HL. Crit Care Med; 2006 Sep 08; 34(9):2310-6. PubMed ID: 16878035 [Abstract] [Full Text] [Related]
7. Red blood cell transfusion threshold in postsurgical pediatric intensive care patients: a randomized clinical trial. Rouette J, Trottier H, Ducruet T, Beaunoyer M, Lacroix J, Tucci M, Canadian Critical Care Trials Group, PALISI Network. Ann Surg; 2010 Mar 08; 251(3):421-7. PubMed ID: 20118780 [Abstract] [Full Text] [Related]
8. Effects of transfusion with red cells filtered to remove leucocytes: randomised controlled trial in patients undergoing major surgery. van Hilten JA, van de Watering LM, van Bockel JH, van de Velde CJ, Kievit J, Brand R, van den Hout WB, Geelkerken RH, Roumen RM, Wesselink RM, Koopman-van Gemert AW, Koning J, Brand A. BMJ; 2004 May 29; 328(7451):1281. PubMed ID: 15142885 [Abstract] [Full Text] [Related]
9. Tranexamic acid and aprotinin in primary cardiac operations: an analysis of 220 cardiac surgical patients treated with tranexamic acid or aprotinin. Dietrich W, Spannagl M, Boehm J, Hauner K, Braun S, Schuster T, Busley R. Anesth Analg; 2008 Nov 29; 107(5):1469-78. PubMed ID: 18931201 [Abstract] [Full Text] [Related]
10. The predictors and outcome of recidivism in cardiac ICUs. Vohra HA, Goldsmith IR, Rosin MD, Briffa NP, Patel RL. Eur J Cardiothorac Surg; 2005 Mar 29; 27(3):508-11. PubMed ID: 15740964 [Abstract] [Full Text] [Related]
11. Effect of dexamethasone on atrial fibrillation after cardiac surgery: prospective, randomized, double-blind, placebo-controlled trial. Yared JP, Bakri MH, Erzurum SC, Moravec CS, Laskowski DM, Van Wagoner DR, Mascha E, Thornton J. J Cardiothorac Vasc Anesth; 2007 Feb 29; 21(1):68-75. PubMed ID: 17289483 [Abstract] [Full Text] [Related]
12. Prognostic value of preoperative cardiac troponin I in patients undergoing emergency coronary artery bypass surgery with non-ST-elevation or ST-elevation acute coronary syndromes. Thielmann M, Massoudy P, Neuhäuser M, Tsagakis K, Marggraf G, Kamler M, Mann K, Erbel R, Jakob H. Circulation; 2006 Jul 04; 114(1 Suppl):I448-53. PubMed ID: 16820617 [Abstract] [Full Text] [Related]
13. Effects of a leukocyte depleting arterial line filter on perioperative morbidity in patients undergoing cardiac surgery: a controlled randomized trial. Leal-Noval SR, Amaya R, Herruzo A, Hernández A, Ordóñez A, Marín-Niebla A, Camacho P. Ann Thorac Surg; 2005 Oct 04; 80(4):1394-400. PubMed ID: 16181877 [Abstract] [Full Text] [Related]
14. Prophylactic nesiritide does not prevent dialysis or all-cause mortality in patients undergoing high-risk cardiac surgery. Ejaz AA, Martin TD, Johnson RJ, Winterstein AG, Klodell CT, Hess PJ, Ali AK, Whidden EM, Staples NL, Alexander JA, House-Fancher MA, Beaver TM. J Thorac Cardiovasc Surg; 2009 Oct 04; 138(4):959-64. PubMed ID: 19660420 [Abstract] [Full Text] [Related]
15. Predictors and outcome of ICU readmission after cardiac surgery. Litmathe J, Kurt M, Feindt P, Gams E, Boeken U. Thorac Cardiovasc Surg; 2009 Oct 04; 57(7):391-4. PubMed ID: 19795324 [Abstract] [Full Text] [Related]
16. Tranexamic acid and aprotinin in low- and intermediate-risk cardiac surgery: a non-sponsored, double-blind, randomised, placebo-controlled trial. Later AF, Maas JJ, Engbers FH, Versteegh MI, Bruggemans EF, Dion RA, Klautz RJ. Eur J Cardiothorac Surg; 2009 Aug 04; 36(2):322-9. PubMed ID: 19250838 [Abstract] [Full Text] [Related]
17. Octogenarians undergoing coronary artery bypass graft surgery: resource utilization, postoperative mortality, and morbidity. Scott BH, Seifert FC, Grimson R, Glass PS. J Cardiothorac Vasc Anesth; 2005 Oct 04; 19(5):583-8. PubMed ID: 16202890 [Abstract] [Full Text] [Related]
18. Does clopidogrel increase blood loss following coronary artery bypass surgery? Chu MW, Wilson SR, Novick RJ, Stitt LW, Quantz MA. Ann Thorac Surg; 2004 Nov 04; 78(5):1536-41. PubMed ID: 15511426 [Abstract] [Full Text] [Related]
19. Perioperative nesiritide versus milrinone in high-risk coronary artery bypass graft patients. Brackbill ML, Stam MD, Schuller-Williams RV, Dhavle AA. Ann Pharmacother; 2007 Mar 04; 41(3):427-32. PubMed ID: 17311834 [Abstract] [Full Text] [Related]